• Odbierz prezent
MILESTONE MEDICAL: Receiving a Notice of Allowance for U.S Patent Related to Breakthrough CompuPulse System (2021-02-24 23:38)
fot. freepik.com

Raport bieżący nr7/2021
Data sporządzenia: 2021-02-24
Skrócona nazwa emitenta
Receiving a Notice of Allowance for U.S Patent Related to Breakthrough CompuPulse System
Podstawa prawna
Art. 17 ust. 1 MAR - informacje poufne.
Treść raportu:
The Board of Directors of Milestone Medical Inc. (WAR: MMD, “the Company”, “the Issuer”), today announced that Milestone Scientific, Inc. (NYSE:MLSS), the licensor and the majority shareholder of the Issuer has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) related to its new CompuPulse System, which integrates the Company’s CompuWave™ technology with a manual syringe.

The Board of Directors of the Company is pleased that its licensor received this Notice of Allowance related to new CompuPulse System, which combines the benefits of CompuWave technology with a manual syringe. Importantly, the new CompuPulse System allows one to identify a pulsatile pressure waveform in a variety of applications, thereby improving the reliability and safety of a drug delivery procedure. Importantly, not all procedures require the sophistication of our CompuFlo system, which precisely controls the administration and flow rate of medication as it is being administered. This new technology provides an efficient and low cost alternative for procedures where a manual syringe may suffice, while still providing the ability to verify needle and subsequent catheter placement.

The Board of Directors of the Company believes that this Notice of Allowance significantly expands the intellectual property of Milestone Scientific surrounding the injection and drug delivery systems and, in turn, further solidifies its leadership position in the computerized injection market. The Board of Directors of the Issuer believes the combination of the CompuWave technology with the lower cost of a manual syringe opens up a number of exciting new markets and applications for the technology, while still ensuring precise confirmation of needle placement and verification that a catheter has not been displaced during or after a procedure.

The Notice of Allowance relates to a method and an apparatus that detects a pulsatile pressure waveform to more easily perform the identification of anatomical target regions. The pulsatile waveform is representative of the detection of pressures that are produced by the cardio-vascular system either directly or indirectly. This same system can be used to aid in the determination of the patency of a catheter and to assist in determining if a catheter has been displaced during a procedure.


(pełna nazwa emitenta)
(skrócona nazwa emitenta)(sektor wg. klasyfikacji GPW w W-wie)
NJ 07039.
(kod pocztowy)(miejscowość)
South Orange Avenue Livingston220
+11 973 535 2717+11 973 535 2829
DataImię i NazwiskoStanowisko/FunkcjaPodpis
2021-02-24Joseph D'AgostinoChief Financial OfficerJoseph D'Agostino


ESPI - Komunikaty spółek

Przejdź do artykułów autora
Artykuły, które powinny Cię zaciekawić..